Showing results (11-20 of 274) with videos related to
Sort By:
Pageof 28
Blood Advances|March 24, 2025
Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic reviewAisling Barrett, Callum Harris, Toby A EyreBritish Journal of Haematology|March 13, 2021
The use of frailty assessments in treating older adults with aggressive lymphomasRaul Cordoba, Stefano Luminari, Toby A EyreHematology/Oncology Clinics of North America|August 31, 2020
What Causes Bruton Tyrosine Kinase Inhibitor Resistance in Mantle Cell Lymphoma and How Should We Treat Such Patients?Rory McCulloch, Toby A Eyre, Simon RuleJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2022
Emerging Therapies for the Management of Richter TransformationElizabeth Smyth, Toby A Eyre, Chan Y CheahCurrent Hematologic Malignancy Reports|June 30, 2019
Front-Line Treatment of High Grade B Cell Non-Hodgkin LymphomaMurali Kesavan, Toby A Eyre, Graham P CollinsBlood|October 22, 2021
Therapeutic options for relapsed/refractory mantle cell lymphomaToby A Eyre, Chan Y Cheah, Michael L WangAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 7, 2026
Modern Management of Mantle Cell LymphomaTobias Tix, Anita Kumar, Toby A Eyre, et al.Klinische Monatsblatter Fur Augenheilkunde|November 17, 2025
[Diagnosis and management of congenital nasolacrimal duct obstruction]Anna SchuhHaematologica|September 7, 2019
Efficacy of central nervous system prophylaxis with stand-alone intrathecal chemotherapy in diffuse large B-cell lymphoma patients treated with anthracycline-based chemotherapy in the rituximab era: a systematic reviewToby A Eyre, Faouzi Djebbari, Amy A Kirkwood, et al.British Journal of Haematology|February 22, 2023
How I manage mantle cell lymphoma: indolent versus aggressive diseaseMatthew R Wilson, Aisling Barrett, Chan Yoon Cheah, et al.Pageof 28